Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.

Krell-Roesch J, Vassilaki M, Mielke MM, Kremers WK, Lowe VJ, Vemuri P, Machulda MM, Christianson TJ, Syrjanen JA, Stokin GB, Butler LM, Traber M, Jack CR Jr, Knopman DS, Roberts RO, Petersen RC, Geda YE.

Transl Psychiatry. 2019 Mar 28;9(1):123. doi: 10.1038/s41398-019-0456-z.

2.

Prevalence of ideal cardiovascular health in a Central European community: results from the Kardiovize Brno 2030 Project.

Medina-Inojosa JR, Vinciguerra M, Maugeri A, Kunzova S, Sochor O, Movsisyan N, Geda YE, Stokin GB, Lopez-Jimenez F.

Eur J Prev Cardiol. 2019 Mar 6:2047487319834875. doi: 10.1177/2047487319834875. [Epub ahead of print] No abstract available.

PMID:
30841746
3.

Deep Brain Stimulation and Cognitive Outcomes Among Patients With Parkinson's Disease: A Historical Cohort Study.

Hansen AL, Krell-Roesch J, Kirlin KA, Limback-Stokin MM, Roesler K, Velgos SN, Lyons MK, Geda YE, Mehta SH.

J Neuropsychiatry Clin Neurosci. 2019 Feb 22:appineuropsych18050118. doi: 10.1176/appi.neuropsych.18050118. [Epub ahead of print]

PMID:
30791806
4.

Excessive Daytime Sleepiness in Major Dementia Syndromes.

Boeve A, Ferman TJ, Aakre J, St Louis E, Silber M, Machulda M, Fields J, Graff-Radford N, Mielke M, Geda Y, Jones D, Graff-Radford J, Knopman D, Petersen R, Boeve B.

Am J Alzheimers Dis Other Demen. 2019 Jun;34(4):261-264. doi: 10.1177/1533317519828046. Epub 2019 Feb 10.

PMID:
30740984
5.

Brain MR Radiomics to Differentiate Cognitive Disorders.

Ranjbar S, Velgos SN, Dueck AC, Geda YE, Mitchell JR; Alzheimer's Disease Neuroimaging Initiative.

J Neuropsychiatry Clin Neurosci. 2019 Jan 14:appineuropsych17120366. doi: 10.1176/appi.neuropsych.17120366. [Epub ahead of print]

PMID:
30636564
6.

Predicting Progression to Mild Cognitive Impairment.

Petersen RC, Lundt ES, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Roberts RO, Lowe VJ, Machulda MM, Kremers WK, Geda YE, Jack CR Jr.

Ann Neurol. 2019 Jan;85(1):155-160. doi: 10.1002/ana.25388. Epub 2019 Jan 7.

PMID:
30521086
7.

Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.

Vassilaki M, Aakre JA, Kremers WK, Mielke MM, Geda YE, Machulda MM, Knopman DS, Coloma PM, Schauble B, Vemuri P, Lowe VJ, Jack CR Jr, Petersen RC, Roberts RO.

J Am Geriatr Soc. 2018 Dec;66(12):2274-2281. doi: 10.1111/jgs.15577. Epub 2018 Nov 21.

PMID:
30462843
8.

Neuropsychological comparison of incident MCI and prevalent MCI.

Hansen A, Caselli RJ, Schlosser-Covell G, Golafshar MA, Dueck AC, Woodruff BK, Stonnington CM, Geda YE, Locke DEC.

Alzheimers Dement (Amst). 2018 Sep 27;10:599-603. doi: 10.1016/j.dadm.2018.08.009. eCollection 2018.

9.

Brain-Derived Neurotrophic Factor and Its Associations with Metabolism and Physical Activity in a Latino Sample.

Fonseca-Portilla R, Krell-Roesch J, Shaibi GQ, Caselli RJ, Mandarino LJ, Zhang N, Hentz JG, Coletta DK, de Filippis EA, Dawit S, Geda YE.

Metab Syndr Relat Disord. 2019 Mar;17(2):75-80. doi: 10.1089/met.2018.0028. Epub 2018 Nov 10.

10.

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy.

Rocca WA, Grossardt BR, Geda YE, Gostout BS, Bower JH, Maraganore DM, de Andrade M, Melton LJ 3rd.

Menopause. 2018 Nov;25(11):1275-1285. doi: 10.1097/GME.0000000000001229.

PMID:
30358723
11.

Sleep Duration and Excessive Daytime Sleepiness Are Associated with Obesity Independent of Diet and Physical Activity.

Maugeri A, Medina-Inojosa JR, Kunzova S, Agodi A, Barchitta M, Sochor O, Lopez-Jimenez F, Geda YE, Vinciguerra M.

Nutrients. 2018 Sep 3;10(9). pii: E1219. doi: 10.3390/nu10091219.

12.

The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons.

Vassilaki M, Aakre JA, Kremers WK, Mielke MM, Geda YE, Alhurani RE, Dutt T, Machulda MM, Knopman DS, Vemuri P, Coloma PM, Schauble B, Lowe VJ, Jack CR, Petersen RC, Roberts RO.

J Gerontol A Biol Sci Med Sci. 2019 May 16;74(6):877-883. doi: 10.1093/gerona/gly149.

PMID:
30124772
13.

Functional Activity and Neuropsychiatric Symptoms in Normal Aging and Mild Cognitive Impairment: The Mayo Clinic Study of Aging.

Krell-Roesch J, Cerhan LP, Machulda MM, Roberts RO, Mielke MM, Knopman DS, Syrjanen JA, Christianson TJ, Petersen RC, Geda YE.

Alzheimer Dis Assoc Disord. 2019 Jan-Mar;33(1):68-71. doi: 10.1097/WAD.0000000000000266. No abstract available.

PMID:
30106755
14.

Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of Aging.

van Harten AC, Mielke MM, Swenson-Dravis DM, Hagen CE, Edwards KK, Roberts RO, Geda YE, Knopman DS, Petersen RC.

Neurology. 2018 Jul 24;91(4):e300-e312. doi: 10.1212/WNL.0000000000005863. Epub 2018 Jun 29.

PMID:
29959257
15.

Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers.

Vassilaki M, Aakre JA, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Alhurani RE, Staubo SC, Knopman DS, Petersen RC, Lowe VJ, Jack CR, Roberts RO.

J Alzheimers Dis. 2018;64(1):281-290. doi: 10.3233/JAD-171121.

16.

Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.

Roberts RO, Aakre JA, Kremers WK, Vassilaki M, Knopman DS, Mielke MM, Alhurani R, Geda YE, Machulda MM, Coloma P, Schauble B, Lowe VJ, Jack CR Jr, Petersen RC.

JAMA Neurol. 2018 Aug 1;75(8):970-979. doi: 10.1001/jamaneurol.2018.0629.

17.

Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging.

Krell-Roesch J, Feder NT, Roberts RO, Mielke MM, Christianson TJ, Knopman DS, Petersen RC, Geda YE.

J Alzheimers Dis. 2018;63(1):149-155. doi: 10.3233/JAD-171141.

18.

Anticholinergic Medications and Cognitive Function in Late Midlife.

Limback-Stokin MM, Krell-Roesch J, Roesler K, Hansen A, Stonnington CM, Temkit M, Caselli RJ, Geda YE.

Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):262-264. doi: 10.1097/WAD.0000000000000251. No abstract available.

PMID:
29481373
19.

Special Issue on mild behavioral impairment and non-cognitive prodromes to dementia.

Mortby ME, Lyketsos CG, Geda YE, Ismail Z.

Int Psychogeriatr. 2018 Feb;30(2):167-169. doi: 10.1017/S1041610218000108.

PMID:
29448971
20.

Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging.

Krell-Roesch J, Lowe VJ, Neureiter J, Pink A, Roberts RO, Mielke MM, Vemuri P, Stokin GB, Christianson TJ, Jack CR, Knopman DS, Boeve BF, Kremers WK, Petersen RC, Geda YE.

Int Psychogeriatr. 2018 Feb;30(2):245-251. doi: 10.1017/S1041610217002368. Epub 2017 Dec 4.

21.

Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.

Roberts RO, Knopman DS, Syrjanen JA, Aakre JA, Vassilaki M, Kremers WK, Mielke MM, Machulda MM, Graff-Radford J, Geda YE, Vemuri P, Lowe V, Jack CR Jr, Petersen RC.

Neurology. 2017 Nov 14;89(20):2039-2048. doi: 10.1212/WNL.0000000000004652. Epub 2017 Oct 13.

22.

Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample.

Jung Y, Boot BP, Mielke MM, Ferman TJ, Geda YE, McDade E, Christianson TJH, Knopman DS, St Louis EK, Silber MH, Petersen RC, Boeve BF.

Alzheimers Dement (Amst). 2017 May 30;8:127-130. doi: 10.1016/j.dadm.2017.05.004. eCollection 2017.

23.

Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging.

Pink A, Przybelski SA, Krell-Roesch J, Stokin GB, Roberts RO, Mielke MM, Knopman DS, Jack CR, Petersen RC, Geda YE.

J Alzheimers Dis. 2017;58(4):1273-1281. doi: 10.3233/JAD-170041.

24.

Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals.

Vassilaki M, Christianson TJ, Mielke MM, Geda YE, Kremers WK, Machulda MM, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Roberts RO.

Ann Neurol. 2017 Jun;81(6):871-882. doi: 10.1002/ana.24960. Epub 2017 Jun 9.

25.

Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Alzheimer Disease: "Which is the Cart and Which is the Horse?"

Geda YE, Krell-Roesch J, Sambuchi N, Michel BF.

Am J Geriatr Psychiatry. 2017 Jul;25(7):694-696. doi: 10.1016/j.jagp.2017.03.007. Epub 2017 Mar 16. No abstract available.

PMID:
28392189
26.

Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.

Krell-Roesch J, Vemuri P, Pink A, Roberts RO, Stokin GB, Mielke MM, Christianson TJ, Knopman DS, Petersen RC, Kremers WK, Geda YE.

JAMA Neurol. 2017 Mar 1;74(3):332-338. doi: 10.1001/jamaneurol.2016.3822.

27.

Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults.

Carvalho DZ, St Louis EK, Boeve BF, Mielke MM, Przybelski SA, Knopman DS, Machulda MM, Roberts RO, Geda YE, Petersen RC, Jack CR Jr, Vemuri P.

Sleep Med. 2017 Apr;32:236-243. doi: 10.1016/j.sleep.2016.08.023. Epub 2016 Nov 3.

28.

The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.

Ismail Z, Agüera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, Gauthier S, Geda YE, Herrmann N, Kanji J, Lanctôt KL, Miller DS, Mortby ME, Onyike CU, Rosenberg PB, Smith EE, Smith GS, Sultzer DL, Lyketsos C; NPS Professional Interest Area of the International Society of to Advance Alzheimer’s Research and Treatment (NPS-PIA of ISTAART).

J Alzheimers Dis. 2017;56(3):929-938. doi: 10.3233/JAD-160979.

29.

Timing of Physical Activity, Apolipoprotein E ε4 Genotype, and Risk of Incident Mild Cognitive Impairment.

Krell-Roesch J, Pink A, Roberts RO, Stokin GB, Mielke MM, Spangehl KA, Bartley MM, Knopman DS, Christianson TJ, Petersen RC, Geda YE.

J Am Geriatr Soc. 2016 Dec;64(12):2479-2486. doi: 10.1111/jgs.14402. Epub 2016 Nov 1.

30.

Cortical Thickness and Anxiety Symptoms Among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.

Pink A, Przybelski SA, Krell-Roesch J, Stokin GB, Roberts RO, Mielke MM, Spangehl KA, Knopman DS, Jack CR Jr, Petersen RC, Geda YE.

J Neuropsychiatry Clin Neurosci. 2017 Winter;29(1):60-66. doi: 10.1176/appi.neuropsych.15100378. Epub 2016 Aug 31.

31.

Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness.

Staubo SC, Aakre JA, Vemuri P, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Knopman DS, Petersen RC, Jack CR Jr, Roberts RO.

Alzheimers Dement. 2017 Feb;13(2):168-177. doi: 10.1016/j.jalz.2016.06.2359. Epub 2016 Jul 25.

32.

FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.

Krell-Roesch J, Ruider H, Lowe VJ, Stokin GB, Pink A, Roberts RO, Mielke MM, Knopman DS, Christianson TJ, Machulda MM, Jack CR, Petersen RC, Geda YE.

J Alzheimers Dis. 2016 Jul 14;53(4):1609-16. doi: 10.3233/JAD-160326.

33.

Apathy associated with neurocognitive disorders: Recent progress and future directions.

Lanctôt KL, Agüera-Ortiz L, Brodaty H, Francis PT, Geda YE, Ismail Z, Marshall GA, Mortby ME, Onyike CU, Padala PR, Politis AM, Rosenberg PB, Siegel E, Sultzer DL, Abraham EH.

Alzheimers Dement. 2017 Jan;13(1):84-100. doi: 10.1016/j.jalz.2016.05.008. Epub 2016 Jun 27. Review.

PMID:
27362291
34.

Impact of Personality on Cognitive Aging: A Prospective Cohort Study.

Caselli RJ, Dueck AC, Locke DE, Henslin BR, Johnson TA, Woodruff BK, Hoffman-Snyder C, Geda YE.

J Int Neuropsychol Soc. 2016 Aug;22(7):765-76. doi: 10.1017/S1355617716000527. Epub 2016 Jun 27.

PMID:
27346168
35.

Multimorbidity and neuroimaging biomarkers among cognitively normal persons.

Vassilaki M, Aakre JA, Mielke MM, Geda YE, Kremers WK, Alhurani RE, Machulda MM, Knopman DS, Petersen RC, Lowe VJ, Jack CR Jr, Roberts RO.

Neurology. 2016 May 31;86(22):2077-84. doi: 10.1212/WNL.0000000000002624. Epub 2016 Apr 13.

36.

Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study.

Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Machulda M, Lowe VJ, Mielke MM, Roberts RO, Gunter JL, Senjem ML, Geda YE, Rocca WA, Petersen RC, Jack CR Jr.

Neurology. 2016 Mar 22;86(12):1128-35. doi: 10.1212/WNL.0000000000002490. Epub 2016 Feb 24.

37.

Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging.

Alhurani RE, Vassilaki M, Aakre JA, Mielke MM, Kremers WK, Machulda MM, Geda YE, Knopman DS, Petersen RC, Roberts RO.

JAMA Neurol. 2016 Apr;73(4):439-46. doi: 10.1001/jamaneurol.2015.4756. Erratum in: JAMA Neurol. 2017 Mar 1;74(3):364.

38.

Frailty and Mortality Outcomes in Cognitively Normal Older People: Sex Differences in a Population-Based Study.

Bartley MM, Geda YE, Christianson TJ, Pankratz VS, Roberts RO, Petersen RC.

J Am Geriatr Soc. 2016 Jan;64(1):132-7. doi: 10.1111/jgs.13821.

39.

[Subjective cognitive impairment and Alzheimer's disease: a two year follow up of 51 subjects during two years].

Sambuchi N, Muraccioli I, Alescio-Lautier B, Paban V, Sambuc R, Jouve É, Geda YE, Petersen RK, Michel BF.

Geriatr Psychol Neuropsychiatr Vieil. 2015 Dec;13(4):462-71. doi: 10.1684/pnv.2015.0575. French.

PMID:
26707564
40.

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community.

Petersen RC, Wiste HJ, Weigand SD, Rocca WA, Roberts RO, Mielke MM, Lowe VJ, Knopman DS, Pankratz VS, Machulda MM, Geda YE, Jack CR Jr.

JAMA Neurol. 2016 Jan;73(1):85-92. doi: 10.1001/jamaneurol.2015.3098. Erratum in: JAMA Neurol. 2016 Apr;73(4):481.

41.

Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.

Roberts RO, Christianson TJ, Kremers WK, Mielke MM, Machulda MM, Vassilaki M, Alhurani RE, Geda YE, Knopman DS, Petersen RC.

JAMA Neurol. 2016 Jan;73(1):93-101. doi: 10.1001/jamaneurol.2015.2952. Erratum in: JAMA Neurol. 2016 Apr;73(4):481.

42.

Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele.

Roberts RO, Aakre JA, Cha RH, Kremers WK, Mielke MM, Velgos SN, Geda YE, Knopman DS, Petersen RC.

Front Aging Neurosci. 2015 Sep 8;7:172. doi: 10.3389/fnagi.2015.00172. eCollection 2015.

43.

Mild Neurocognitive Disorder: An Old Wine in a New Bottle.

Stokin GB, Krell-Roesch J, Petersen RC, Geda YE.

Harv Rev Psychiatry. 2015 Sep-Oct;23(5):368-76. doi: 10.1097/HRP.0000000000000084. Review.

44.

Multimorbidity and Risk of Mild Cognitive Impairment.

Vassilaki M, Aakre JA, Cha RH, Kremers WK, St Sauver JL, Mielke MM, Geda YE, Machulda MM, Knopman DS, Petersen RC, Roberts RO.

J Am Geriatr Soc. 2015 Sep;63(9):1783-90. doi: 10.1111/jgs.13612. Epub 2015 Aug 27.

45.

Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, Agüera-Ortiz L, Sweet R, Miller D, Lyketsos CG; ISTAART Neuropsychiatric Symptoms Professional Interest Area.

Alzheimers Dement. 2016 Feb;12(2):195-202. doi: 10.1016/j.jalz.2015.05.017. Epub 2015 Jun 18.

46.

White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging.

Nedelska Z, Schwarz CG, Boeve BF, Lowe VJ, Reid RI, Przybelski SA, Lesnick TG, Gunter JL, Senjem ML, Ferman TJ, Smith GE, Geda YE, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

Neurobiol Aging. 2015 Jun;36(6):2010-7. doi: 10.1016/j.neurobiolaging.2015.03.007. Epub 2015 Mar 14.

47.

Risk and protective factors for cognitive impairment in persons aged 85 years and older.

Roberts RO, Cha RH, Mielke MM, Geda YE, Boeve BF, Machulda MM, Knopman DS, Petersen RC.

Neurology. 2015 May 5;84(18):1854-61. doi: 10.1212/WNL.0000000000001537. Epub 2015 Apr 8.

48.

APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.

Krell-Roesch J, Woodruff BK, Acosta JI, Locke DE, Hentz JG, Stonnington CM, Stokin GB, Nagle C, Michel BF, Sambuchi N, Caselli RJ, Geda YE.

J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):322-5. doi: 10.1176/appi.neuropsych.14100268. Epub 2015 Mar 24.

49.

Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging.

Pankratz VS, Roberts RO, Mielke MM, Knopman DS, Jack CR Jr, Geda YE, Rocca WA, Petersen RC.

Neurology. 2015 Apr 7;84(14):1433-42. doi: 10.1212/WNL.0000000000001437. Epub 2015 Mar 18.

50.

Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: the Mayo Clinic Study of Aging.

Vassilaki M, Cha RH, Aakre JA, Therneau TM, Geda YE, Mielke MM, Knopman DS, Petersen RC, Roberts RO.

J Alzheimers Dis. 2015;45(4):1237-45. doi: 10.3233/JAD-143078.

Supplemental Content

Support Center